GTCM
NBP

Gyon Technologies Capital Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Gyon Technologies Capital Management’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-18,528
Closed -$209K – 483
2022
Q2 		$209K Buy
+18,528
New +$222K 0.06% 402

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Gyon Technologies Capital Management's NBP Position: Q3 2022 in Review

Gyon Technologies Capital Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2022, closing a stake of 18,528 shares — an estimated $209K sold.

Gyon Technologies Capital Management first reported a position in NBP in Q2 2022 and held it in 1 quarter. The position peaked at $209K in Q2 2022. 75 funds tracked by Wall St. Rank hold NBP as of Q3 2022.

  • Gyon Technologies Capital Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 18,528 NovaBridge Biosciences American Depositary Shares shares in Q3 2022, an estimated $209K.
  • Gyon Technologies Capital Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2022 and held it in 1 quarter.
  • Gyon Technologies Capital Management's NovaBridge Biosciences American Depositary Shares position peaked at $209K in Q2 2022.
  • 75 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2022.

Based on Gyon Technologies Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.